David Matthew Stark is CLO & VP at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA). They have made 13 open-market trades across 1 company since 2018, most recently 2026-05-05.
CIK 0001722360
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ASRT | SELL · 10b5-1 | 2025-11-10 | 2025-11-12 | $0.76 | $7K | -15.3% | -9.4% | -7.4% |
| TEVA | SELL | 2023-03-06 | 2023-03-08 | $9.55 | $1.3M | -11.5% | -2.4% | -25.0% |
| TEVA | SELL | 2023-02-28 | 2023-03-02 | $9.89 | $1.3M | -10.9% | -8.8% | -28.0% |
| TEVA | SELL | 2022-07-28 | 2022-07-29 | $9.04 | $1.1M | +21.5% | +2.0% | -5.7% |
| TEVA | SELL | 2022-03-04 | 2022-03-08 | $7.45 | $435K | +4.1% | +34.3% | +19.5% |
| TEVA | SELL | 2022-02-28 | 2022-03-02 | $8.14 | $105K | -7.2% | +18.7% | +15.0% |
| TEVA | SELL | 2022-02-09 | 2022-02-10 | $9.06 | $111K | -9.0% | -16.6% | -16.2% |
| TEVA | SELL | 2021-05-11 | 2021-05-13 | $10.22 | $774K | -0.2% | +5.2% | -3.0% |
| TEVA | SELL | 2021-03-04 | 2021-03-08 | $10.57 | $294K | +5.6% | +5.0% | -0.5% |
| TEVA | SELL | 2021-03-01 | 2021-03-02 | $10.83 | $399K | -0.1% | +6.3% | -2.8% |
| TEVA | SELL · 10b5-1 | 2021-02-16 | 2021-02-17 | $11.12 | $44K | -2.2% | +3.1% | -4.5% |
| TEVA | SELL | 2021-02-09 | 2021-02-11 | $12.69 | $1.7M | +0.2% | -1.3% | -9.1% |
| TEVA | SELL · 10b5-1 | 2020-03-17 | 2020-03-19 | $7.16 | $17K | +10.9% | +27.4% | +48.6% |
| TEVA | SELL | 2020-02-14 | 2020-02-18 | $12.14 | $365K | -7.9% | -42.7% | -6.0% |
| TEVA | SELL | 2020-02-10 | 2020-02-11 | $12.24 | $307K | -3.0% | -40.4% | -12.5% |
| TEVA | SELL · 10b5-1 | 2019-03-18 | 2019-03-19 | $16.43 | $39K | -6.9% | -14.8% | -51.3% |
| TEVA | SELL · 10b5-1 | 2019-03-12 | 2019-03-14 | $15.82 | $39K | -3.7% | -11.9% | -47.3% |
| TEVA | SELL | 2019-02-14 | 2019-02-19 | $17.74 | $139K | -4.6% | -4.6% | -35.8% |
| TEVA | SELL · 10b5-1 | 2018-03-19 | 2018-03-20 | $18.38 | $43K | -4.9% | +0.5% | +37.4% |
| TEVA | SELL · 10b5-1 | 2018-03-12 | 2018-03-14 | $19.20 | $47K | -9.3% | -3.0% | +29.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.